![](https://img.einpresswire.com/small/814752/cov-biotechnology-takes-next-st.png)
CoV Biotechnology Takes Next Step to Become Leyden Labs Asia
Advancing its Mission to Combat Respiratory Infectious Diseases SINGAPORE, SINGPORE, SINGAPORE, January 22, 2025 /EINPresswire.com/ -- - CoV Biotechnology has been acquired by Leyden Labs and continues as Leyden Labs Asia on the global biotech stage. …